USA Granulocyte Macrophage Colony Stimulating Factor Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Granulocyte Macrophage Colony Stimulating Factor market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Granulocyte Macrophage Colony Stimulating Factor market. Detailed analysis of key players, along with key growth strategies adopted by Granulocyte Macrophage Colony Stimulating Factor industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Mologen AG

    • Sillajen Biotherapeutics

    • Morphotek Inc

    • BriaCell Therapeutics Corp

    • GlaxoSmithKline Plc

    • Cold Genesys Inc

    • Takeda Pharmaceutical Co Ltd

    • Humanigen Inc

    • Aduro BioTech Inc

    • Amgen Inc

    By Type:

    • CG-0070

    • Gimsilumab

    • GSK-3196165

    • Lenzilumab

    • MGN-1601

    • Others

    By End-User:

    • Solid Tumor

    • Lymphoma

    • Kidney Cancer

    • Lung Disease

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Granulocyte Macrophage Colony Stimulating Factor Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070 from 2016 to 2027

      • 1.3.2 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab from 2016 to 2027

      • 1.3.3 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165 from 2016 to 2027

      • 1.3.4 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab from 2016 to 2027

      • 1.3.5 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601 from 2016 to 2027

      • 1.3.6 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Solid Tumor from 2016 to 2027

      • 1.4.2 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lymphoma from 2016 to 2027

      • 1.4.3 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Kidney Cancer from 2016 to 2027

      • 1.4.4 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lung Disease from 2016 to 2027

      • 1.4.5 USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Granulocyte Macrophage Colony Stimulating Factor Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Granulocyte Macrophage Colony Stimulating Factor by Major Types

      • 3.4.1 Market Size and Growth Rate of CG-0070

      • 3.4.2 Market Size and Growth Rate of Gimsilumab

      • 3.4.3 Market Size and Growth Rate of GSK-3196165

      • 3.4.4 Market Size and Growth Rate of Lenzilumab

      • 3.4.5 Market Size and Growth Rate of MGN-1601

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Granulocyte Macrophage Colony Stimulating Factor Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Granulocyte Macrophage Colony Stimulating Factor by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Solid Tumor

      • 4.4.2 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Lymphoma

      • 4.4.3 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Kidney Cancer

      • 4.4.4 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Lung Disease

      • 4.4.5 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor in Others

    5 Market Analysis by Regions

    • 5.1 USA Granulocyte Macrophage Colony Stimulating Factor Production Analysis by Regions

    • 5.2 USA Granulocyte Macrophage Colony Stimulating Factor Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 6.1 West USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 6.2 West USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    7 South USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 7.1 South USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 7.2 South USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    8 Middle West USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 8.1 Middle West USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 8.2 Middle West USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    9 Northeast USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 9.1 Northeast USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 9.2 Northeast USA Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Mologen AG

        • 10.1.1 Mologen AG Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Sillajen Biotherapeutics

        • 10.2.1 Sillajen Biotherapeutics Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Morphotek Inc

        • 10.3.1 Morphotek Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 BriaCell Therapeutics Corp

        • 10.4.1 BriaCell Therapeutics Corp Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 GlaxoSmithKline Plc

        • 10.5.1 GlaxoSmithKline Plc Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Cold Genesys Inc

        • 10.6.1 Cold Genesys Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Takeda Pharmaceutical Co Ltd

        • 10.7.1 Takeda Pharmaceutical Co Ltd Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Humanigen Inc

        • 10.8.1 Humanigen Inc Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Aduro BioTech Inc

        • 10.9.1 Aduro BioTech Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Amgen Inc

        • 10.10.1 Amgen Inc Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070 from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165 from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601 from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Solid Tumor from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lymphoma from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Kidney Cancer from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lung Disease from 2016 to 2027

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Granulocyte Macrophage Colony Stimulating Factor Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Granulocyte Macrophage Colony Stimulating Factor

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Granulocyte Macrophage Colony Stimulating Factor by Different Types from 2016 to 2027

    • Table Consumption Share of Granulocyte Macrophage Colony Stimulating Factor by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of CG-0070

    • Figure Market Size and Growth Rate of Gimsilumab

    • Figure Market Size and Growth Rate of GSK-3196165

    • Figure Market Size and Growth Rate of Lenzilumab

    • Figure Market Size and Growth Rate of MGN-1601

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Granulocyte Macrophage Colony Stimulating Factor by Different End-Users from 2016 to 2027

    • Table Consumption Share of Granulocyte Macrophage Colony Stimulating Factor by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Solid Tumor

    • Figure Market Size and Growth Rate of Lymphoma

    • Figure Market Size and Growth Rate of Kidney Cancer

    • Figure Market Size and Growth Rate of Lung Disease

    • Figure Market Size and Growth Rate of Others

    • Table USA Granulocyte Macrophage Colony Stimulating Factor Production by Regions

    • Table USA Granulocyte Macrophage Colony Stimulating Factor Production Share by Regions

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Production Share by Regions in 2016

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Production Share by Regions in 2021

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Production Share by Regions in 2027

    • Table USA Granulocyte Macrophage Colony Stimulating Factor Consumption by Regions

    • Table USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Regions

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Regions in 2016

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Regions in 2021

    • Figure USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Regions in 2027

    • Table West USA Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2016 to 2027

    • Table West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2016 to 2027

    • Figure West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2016

    • Figure West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2021

    • Figure West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2027

    • Table West USA Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2016 to 2027

    • Table West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2016

    • Figure West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2021

    • Figure West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2027

    • Table South USA Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2016 to 2027

    • Table South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2016 to 2027

    • Figure South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2016

    • Figure South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2021

    • Figure South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2027

    • Table South USA Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2016 to 2027

    • Table South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2016

    • Figure South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2021

    • Figure South USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2027

    • Table Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2016 to 2027

    • Table Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2016

    • Figure Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2021

    • Figure Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2027

    • Table Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2016

    • Figure Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2021

    • Figure Middle West USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2027

    • Table Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2016 to 2027

    • Table Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2016

    • Figure Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2021

    • Figure Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types in 2027

    • Table Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2016

    • Figure Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2021

    • Figure Northeast USA Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Mologen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mologen AG

    • Figure Sales and Growth Rate Analysis of Mologen AG

    • Figure Revenue and Market Share Analysis of Mologen AG

    • Table Product and Service Introduction of Mologen AG

    • Table Company Profile and Development Status of Sillajen Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sillajen Biotherapeutics

    • Figure Sales and Growth Rate Analysis of Sillajen Biotherapeutics

    • Figure Revenue and Market Share Analysis of Sillajen Biotherapeutics

    • Table Product and Service Introduction of Sillajen Biotherapeutics

    • Table Company Profile and Development Status of Morphotek Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Morphotek Inc

    • Figure Sales and Growth Rate Analysis of Morphotek Inc

    • Figure Revenue and Market Share Analysis of Morphotek Inc

    • Table Product and Service Introduction of Morphotek Inc

    • Table Company Profile and Development Status of BriaCell Therapeutics Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BriaCell Therapeutics Corp

    • Figure Sales and Growth Rate Analysis of BriaCell Therapeutics Corp

    • Figure Revenue and Market Share Analysis of BriaCell Therapeutics Corp

    • Table Product and Service Introduction of BriaCell Therapeutics Corp

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Cold Genesys Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cold Genesys Inc

    • Figure Sales and Growth Rate Analysis of Cold Genesys Inc

    • Figure Revenue and Market Share Analysis of Cold Genesys Inc

    • Table Product and Service Introduction of Cold Genesys Inc

    • Table Company Profile and Development Status of Takeda Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Takeda Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Humanigen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Humanigen Inc

    • Figure Sales and Growth Rate Analysis of Humanigen Inc

    • Figure Revenue and Market Share Analysis of Humanigen Inc

    • Table Product and Service Introduction of Humanigen Inc

    • Table Company Profile and Development Status of Aduro BioTech Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aduro BioTech Inc

    • Figure Sales and Growth Rate Analysis of Aduro BioTech Inc

    • Figure Revenue and Market Share Analysis of Aduro BioTech Inc

    • Table Product and Service Introduction of Aduro BioTech Inc

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.